Cargando…
A novel m6A‐related prognostic signature for predicting the overall survival of hepatocellular carcinoma patients
Liver hepatocellular carcinoma (LIHC) comprises most cases of liver cancer with a poor prognosis. N (6)‐methyladenosine (m6A) plays important biological functions in cancers. Thus, the present research was aimed to determine biomarkers of m6A regulators that could effectively predict the prognosis o...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849219/ https://www.ncbi.nlm.nih.gov/pubmed/34647424 http://dx.doi.org/10.1049/syb2.12036 |